Cancer in patients on chronic dialysis in Korea

Jung Eun Lee, Seung Hyeok Han, Byoung Chul Cho, Jung Tak Park, Tae Hyun Yoo, Beom Seok Kim, Hyeong Cheon Park, Shin Wook Kang, Ho Yung Lee, Dae Suk Han, Sung Kyu Ha, Kyu Hun Choi

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The study of cancer in patients treated with dialysis in Korea has not been reported. The aim of this study was to investigate the incidence and mortality of cancer among patients on dialysis in Korea. The study subjects were 106 cancer patients (2.3%) out of 4,562 end-stage renal disease (ESRD) patients maintained on hemodialysis (HD) or peritoneal dialysis (PD) at Yonsei University Health System from 1996 to 2005. We excluded patients in whom the diagnosis of cancer preceded dialysis or those who received renal allograft or started dialysis after renal allograft. Seventy-three (69%) of our subjects were male and 33 (31%) were female. The mean age at the time of cancer diagnosis was 57.9±11.7 yr. The mean time from the start of dialysis to the diagnosis of cancer was 75.2±63.9 months. The most common cancer site was gastrointestinal tract (GIT) (51%) followed by urinary tract (20%), lung (8%), and thyroid (7%). Sixty nine percent of the total mortality was due to cancer. The mean time from diagnosis to death was 2.9±2.5 yr. In ESRD patients with cancer, there were no significant differences in mortality rates by dialysis modality. In ESRD patients, the most common cancer was GIT cancer followed by urinary tract cancer. Therefore, careful surveillance of these cancers in ESRD patients is highly recommended.

Original languageEnglish
Pages (from-to)S95-S101
JournalJournal of Korean medical science
Volume24
Issue numberSUPPL.1
DOIs
Publication statusPublished - 2009 Jan 1

Fingerprint

Korea
Dialysis
Neoplasms
Chronic Kidney Failure
Urologic Neoplasms
Gastrointestinal Neoplasms
Allografts
Renal Dialysis
Mortality
Peritoneal Dialysis
Urinary Tract
Gastrointestinal Tract
Thyroid Gland
Kidney
Lung
Incidence
Health

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Lee, Jung Eun ; Han, Seung Hyeok ; Cho, Byoung Chul ; Park, Jung Tak ; Yoo, Tae Hyun ; Kim, Beom Seok ; Park, Hyeong Cheon ; Kang, Shin Wook ; Lee, Ho Yung ; Han, Dae Suk ; Ha, Sung Kyu ; Choi, Kyu Hun. / Cancer in patients on chronic dialysis in Korea. In: Journal of Korean medical science. 2009 ; Vol. 24, No. SUPPL.1. pp. S95-S101.
@article{574d693b1ad44d07b19679409b9fe6db,
title = "Cancer in patients on chronic dialysis in Korea",
abstract = "The study of cancer in patients treated with dialysis in Korea has not been reported. The aim of this study was to investigate the incidence and mortality of cancer among patients on dialysis in Korea. The study subjects were 106 cancer patients (2.3{\%}) out of 4,562 end-stage renal disease (ESRD) patients maintained on hemodialysis (HD) or peritoneal dialysis (PD) at Yonsei University Health System from 1996 to 2005. We excluded patients in whom the diagnosis of cancer preceded dialysis or those who received renal allograft or started dialysis after renal allograft. Seventy-three (69{\%}) of our subjects were male and 33 (31{\%}) were female. The mean age at the time of cancer diagnosis was 57.9±11.7 yr. The mean time from the start of dialysis to the diagnosis of cancer was 75.2±63.9 months. The most common cancer site was gastrointestinal tract (GIT) (51{\%}) followed by urinary tract (20{\%}), lung (8{\%}), and thyroid (7{\%}). Sixty nine percent of the total mortality was due to cancer. The mean time from diagnosis to death was 2.9±2.5 yr. In ESRD patients with cancer, there were no significant differences in mortality rates by dialysis modality. In ESRD patients, the most common cancer was GIT cancer followed by urinary tract cancer. Therefore, careful surveillance of these cancers in ESRD patients is highly recommended.",
author = "Lee, {Jung Eun} and Han, {Seung Hyeok} and Cho, {Byoung Chul} and Park, {Jung Tak} and Yoo, {Tae Hyun} and Kim, {Beom Seok} and Park, {Hyeong Cheon} and Kang, {Shin Wook} and Lee, {Ho Yung} and Han, {Dae Suk} and Ha, {Sung Kyu} and Choi, {Kyu Hun}",
year = "2009",
month = "1",
day = "1",
doi = "10.3346/jkms.2009.24.S1.S95",
language = "English",
volume = "24",
pages = "S95--S101",
journal = "Journal of Korean Medical Science",
issn = "1011-8934",
publisher = "Korean Academy of Medical Science",
number = "SUPPL.1",

}

Lee, JE, Han, SH, Cho, BC, Park, JT, Yoo, TH, Kim, BS, Park, HC, Kang, SW, Lee, HY, Han, DS, Ha, SK & Choi, KH 2009, 'Cancer in patients on chronic dialysis in Korea', Journal of Korean medical science, vol. 24, no. SUPPL.1, pp. S95-S101. https://doi.org/10.3346/jkms.2009.24.S1.S95

Cancer in patients on chronic dialysis in Korea. / Lee, Jung Eun; Han, Seung Hyeok; Cho, Byoung Chul; Park, Jung Tak; Yoo, Tae Hyun; Kim, Beom Seok; Park, Hyeong Cheon; Kang, Shin Wook; Lee, Ho Yung; Han, Dae Suk; Ha, Sung Kyu; Choi, Kyu Hun.

In: Journal of Korean medical science, Vol. 24, No. SUPPL.1, 01.01.2009, p. S95-S101.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cancer in patients on chronic dialysis in Korea

AU - Lee, Jung Eun

AU - Han, Seung Hyeok

AU - Cho, Byoung Chul

AU - Park, Jung Tak

AU - Yoo, Tae Hyun

AU - Kim, Beom Seok

AU - Park, Hyeong Cheon

AU - Kang, Shin Wook

AU - Lee, Ho Yung

AU - Han, Dae Suk

AU - Ha, Sung Kyu

AU - Choi, Kyu Hun

PY - 2009/1/1

Y1 - 2009/1/1

N2 - The study of cancer in patients treated with dialysis in Korea has not been reported. The aim of this study was to investigate the incidence and mortality of cancer among patients on dialysis in Korea. The study subjects were 106 cancer patients (2.3%) out of 4,562 end-stage renal disease (ESRD) patients maintained on hemodialysis (HD) or peritoneal dialysis (PD) at Yonsei University Health System from 1996 to 2005. We excluded patients in whom the diagnosis of cancer preceded dialysis or those who received renal allograft or started dialysis after renal allograft. Seventy-three (69%) of our subjects were male and 33 (31%) were female. The mean age at the time of cancer diagnosis was 57.9±11.7 yr. The mean time from the start of dialysis to the diagnosis of cancer was 75.2±63.9 months. The most common cancer site was gastrointestinal tract (GIT) (51%) followed by urinary tract (20%), lung (8%), and thyroid (7%). Sixty nine percent of the total mortality was due to cancer. The mean time from diagnosis to death was 2.9±2.5 yr. In ESRD patients with cancer, there were no significant differences in mortality rates by dialysis modality. In ESRD patients, the most common cancer was GIT cancer followed by urinary tract cancer. Therefore, careful surveillance of these cancers in ESRD patients is highly recommended.

AB - The study of cancer in patients treated with dialysis in Korea has not been reported. The aim of this study was to investigate the incidence and mortality of cancer among patients on dialysis in Korea. The study subjects were 106 cancer patients (2.3%) out of 4,562 end-stage renal disease (ESRD) patients maintained on hemodialysis (HD) or peritoneal dialysis (PD) at Yonsei University Health System from 1996 to 2005. We excluded patients in whom the diagnosis of cancer preceded dialysis or those who received renal allograft or started dialysis after renal allograft. Seventy-three (69%) of our subjects were male and 33 (31%) were female. The mean age at the time of cancer diagnosis was 57.9±11.7 yr. The mean time from the start of dialysis to the diagnosis of cancer was 75.2±63.9 months. The most common cancer site was gastrointestinal tract (GIT) (51%) followed by urinary tract (20%), lung (8%), and thyroid (7%). Sixty nine percent of the total mortality was due to cancer. The mean time from diagnosis to death was 2.9±2.5 yr. In ESRD patients with cancer, there were no significant differences in mortality rates by dialysis modality. In ESRD patients, the most common cancer was GIT cancer followed by urinary tract cancer. Therefore, careful surveillance of these cancers in ESRD patients is highly recommended.

UR - http://www.scopus.com/inward/record.url?scp=62449266345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62449266345&partnerID=8YFLogxK

U2 - 10.3346/jkms.2009.24.S1.S95

DO - 10.3346/jkms.2009.24.S1.S95

M3 - Article

C2 - 19194570

AN - SCOPUS:62449266345

VL - 24

SP - S95-S101

JO - Journal of Korean Medical Science

JF - Journal of Korean Medical Science

SN - 1011-8934

IS - SUPPL.1

ER -